Hello, Thanks for signing up for MarketBeat Daily Ratings—we’re excited to have you on board. Every weekday, you’ll get a curated summary of new “Buy” and “Sell” ratings from Wall Street’s top-rated analysts, the latest stock news, and bonus investing content—all delivered straight to your inbox. You’re just two quick steps away from completing your sign-up: 1. Make sure our emails go to your inboxGmail users:
Mobile: Tap the three dots (…) in the top right and select Move to Inbox or Move to Primary
Desktop: Click the folder icon at the top and select Move to Inbox or Primary Apple Mail users:
Tap our email address at the top (next to From: on mobile), then select Add to VIP Other providers:
Reply to this message and add newsletters@analystratings.net to your contacts 2. Confirm your subscriptionClick this link to confirm your subscription. This verifies your account and ensures you receive your newsletters without interruption instead of getting stuck in your spam filter. Confirm your subscription here. After you confirm, feel free to download our popular free report, "7 Stocks to Buy and Hold Forever" with this link. Thanks again for subscribing—we look forward to being part of your investing journey. 
Matthew Paulson
Founder and CEO, MarketBeat. P.S. If you didn’t mean to subscribe, no problem—you can unsubscribe here.
Just For You
3 Oversold Healthcare Stocks to Buy After Jobs DataReported by Chris Markoch. Posted: 4/13/2026. 
Key Points
- Strong March job growth in healthcare is reinforcing the sector’s defensive appeal, creating opportunities to buy high-quality stocks after recent pullbacks.
- HCA Healthcare and Tenet Healthcare stand out for their scale, earnings strength, and institutional support, with both stocks rebounding from oversold levels.
- Universal Health Services offers turnaround potential and added upside from its Talkspace acquisition, positioning it for recovery as sentiment improves.
- Special Report: Elon Musk already made me a “wealthy man”
The March jobs report released on April 3 showed an impressive 178,000 jobs were created. Of that number, 76,000 were in the healthcare sector. This reversed a decline in healthcare jobs from the prior quarter. Most of those gains were concentrated in hospitals and ambulatory care services. For investors, the report reinforces the case for select healthcare stocks—especially when they are seeking defensive names that offer both safety and modest growth.
For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is.
The healthcare sector is well suited to deliver that mix because of an aging population and steady utilization of services. Those dynamics create opportunities when solid companies pull back. This article highlights three such names. Each combines operational strength, earnings power, and attractive valuation characteristics. More importantly, each benefits from ongoing demand for medical care even when the labor backdrop is uneven. HCA Healthcare: A Scaled Leader With Defensive AppealHCA Healthcare (NYSE: HCA) owns and operates a network of hospitals and related facilities, including acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s scale gives it leverage in staffing, purchasing, and operations, helping to offset cost pressure. HCA traded into oversold territory in late March but rallied after the jobs report to hover around its 50-day simple moving average (SMA). It has pulled back slightly since then, but a consensus price target of $537.73 points to healthy upside. 
Analysts have raised targets after the company’s strong earnings report. HCA beat on both the top and bottom lines and issued constructive full-year guidance. For investors seeking a steadier healthcare rebound, HCA offers a clean profile: defensive demand, operating efficiency, and a long track record of execution. At roughly 17x earnings, it trades at a slight premium to the sector average, but it remains an attractive buy on pullbacks. Tenet Healthcare: Momentum and Institutional Support Stand OutTenet Healthcare Corp. (NYSE: THC), a competitor of HCA, has risen more than 50% over the past year. That performance was backed by strong revenue and earnings gains year over year. Its chart has moved similarly to HCA’s: the stock was touching oversold levels in late March and has climbed since the jobs report, bouncing off a prior support level from January. 
Tenet is widely held by institutions—institutional ownership exceeds 95%. Institutional investors have not been passive: buying activity has outpaced selling by nearly 2:1 and remained consistent across the last four quarters. Analysts are also bullish. Even with a 7.4% rally in THC in the five trading days ending April 9, the stock remains roughly 30% below its consensus price target of $250.56. Universal Health Services: A Turnaround With Digital UpsideUniversal Health Services (NYSE: UHS) is another diversified healthcare management company with a portfolio similar to Tenet and HCA. UHS has a unique near-term catalyst: it recently announced it will acquire Talkspace (NASDAQ: TALK), giving the company a meaningful foothold in digital mental health. UHS is down about 17% in 2026, in part due to an earnings miss that reversed a rally that began in late January. Like the other names on this list, UHS bounced off oversold levels in late March and is attempting to recover. 
Analysts are generally constructive, assigning UHS a consensus price target of $232.21, which implies nearly 30% upside. The stock also has strong institutional ownership—about 86%—and buying has consistently outpaced selling over the last four quarters. Bottom line: HCA, Tenet, and Universal Health Services each offer a different path to benefit from steady healthcare demand—through scale and efficiency, institutional momentum, or digital expansion. For investors seeking defensive exposure with upside potential, these names are worth watching on pullbacks. As always, consider your investment horizon and risk tolerance and do your own due diligence before acting. |
Post a Comment
0Comments